• If you are wondering whether Avient shares are offering fair value at around US$40.88, starting with a clear look at what the current price actually reflects can be helpful.
• Over the short term the stock has had mixed moves, with a 2.9% decline over the last 7 days, a 13.1% return over 30 days, and returns of 28.9% year to date and 2.2% over 1 year, while the 3 year and 5 year returns sit at 3.3% and a 2.9% decline respectively.
• These swings sit against a backdrop of ongoing company updates and sector news that continue to shape how investors think about specialty materials businesses. For Avient, that context is important because sentiment around the industry and the company’s capital allocation decisions can quickly feed through into the share price, even when the underlying operations do not change overnight.
• On our valuation checks, Avient scores 3 out of 6 for potential undervaluation, giving it a value score of 3. Next, we will walk through what different valuation approaches say about that number and then finish with a bigger-picture tool that can help you judge whether the valuation really stacks up.

Approach 1: Avient Discounted Cash Flow (DCF) Analysis

A Discounted Cash Flow, or DCF, model takes the cash Avient is expected to generate in the future and discounts those projections back to what they could be worth in today’s dollars. It is essentially asking what you might be willing to pay now for those future cash flows.

For Avient, the model used is a 2 Stage Free Cash Flow to Equity approach, based on free cash flow to shareholders. The latest twelve month free cash flow is about $184 million. Analyst estimates and subsequent extrapolations then project free cash flow out over the coming years, reaching about $324 million by 2035, with $258 million projected for 2028. Simply Wall St notes that analyst inputs are only available for the earlier part of that period and later years are extrapolated.

Putting all of those projected cash flows together and discounting them back, the model arrives at an estimated intrinsic value of about $51.97 per share. Against a current share price of around $40.88, this implies the shares trade at roughly a 21.3% discount. On this DCF view, they appear to be undervalued.

Result: UNDERVALUED

Our Discounted Cash Flow (DCF) analysis suggests Avient is undervalued by 21.3%. Track this in your watchlist or portfolio, or discover 45 more high quality undervalued stocks.

Approach 2: Avient Price vs Earnings

For a profitable company like Avient, the P/E ratio is a straightforward way to link what you pay today with the earnings the business is currently generating. Investors usually accept a higher P/E when they expect stronger growth or see lower risk, and look for a lower P/E when growth is more modest or risks feel higher.

Avient trades on a P/E of about 45.7x. That sits above the Chemicals industry average of about 24.0x and also above the peer average of around 26.7x, so on simple comparisons the shares carry a richer earnings multiple than many sector peers.

Simply Wall St’s Fair Ratio for Avient is 30.3x. This is a proprietary estimate of what Avient’s P/E might be given factors such as its earnings growth profile, profit margin, industry, market cap and company specific risks. Because it blends these drivers into a single yardstick, the Fair Ratio can give you a more tailored reference point than a broad industry or peer average. Comparing Avient’s current P/E of 45.7x with the Fair Ratio of 30.3x suggests the shares are pricing in more than that framework would indicate.

Result: OVERVALUED

P/E ratios tell one story, but what if the real opportunity lies elsewhere? Start investing in legacies, not executives. Discover our 19 top founder-led companies.

Upgrade Your Decision Making: Choose your Avient Narrative

Earlier we mentioned that there is an even better way to understand valuation, so Narratives on Simply Wall St let you attach a clear story about Avient to the numbers by linking your view of its future revenue, earnings and margins to a financial forecast and fair value. You can then compare that fair value with the current price to help you decide if the shares look attractive or not. Each Narrative lives on the Community page and updates automatically when new information such as news or earnings comes in. This allows very different viewpoints to coexist. For example, one investor might align with the higher fair value around US$56.00 that assumes stronger growth and margins, while another might lean toward a more cautious fair value near US$34.00. Both are simply expressing their own assumptions within the same easy to use framework.

For Avient, here are previews of two leading Avient Narratives to make things easier to review:

Fair value in this bullish narrative: US$48.25 per share

Discount versus last close of US$40.88: about 15.3% below the narrative fair value

Revenue growth assumption: 3.22% a year

• Focuses on growth in higher value healthcare and sustainable materials, with an emphasis on premium products and margin support from these segments.
• Highlights productivity efforts, cost controls and debt reduction as key supports for free cash flow and flexibility to keep investing in core growth areas.
• Flags risks around demand weakness in some end markets, raw material cost swings, regulation and sustainability expectations that could challenge revenue and margins.

Fair value in this bearish narrative: US$34.00 per share

Premium versus last close of US$40.88: about 20.2% above the narrative fair value

Revenue growth assumption: 2.03% a year

• Points out that faster growing healthcare and defense exposures are still a smaller slice of the business, so they only partly offset softer demand in larger consumer and packaging areas.
• Assumes modest revenue growth, with productivity benefits and plant optimization helping margins, but with wage inflation and restructuring needs potentially absorbing part of the gains.
• Builds in a lower future P/E and a higher discount rate, reflecting caution around how quickly Avient can convert its growth vectors into broad based earnings progress.

Together, these Narratives show how different assumptions on growth, margins and valuation can lead to very different fair value views for the same Avient share price. If you want to go beyond these previews, you can read the full bull and bear cases, then adjust the inputs to match your own view of the business and its risks.

Do you think there's more to the story for Avient? Head over to our Community to see what others are saying!

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.